# Urothelial Carcinoma of the Penile Urethra as a Potential Secondary Complication of Junctional Epidermolysis Bullosa: A Case Report and Review of the Literature

**Authors:** Jessica McClatchy, Ingrid Winship, Laura Scardamaglia, Vanessa Morgan, Gayle Ross

PMC · DOI: 10.1155/crdm/5549697 · Case Reports in Dermatological Medicine · 2026-02-23

## TL;DR

A man with a rare skin condition developed a rare type of cancer in his urethra, possibly due to chronic inflammation from his disease.

## Contribution

This case report highlights a potential link between junctional epidermolysis bullosa and penile urethral urothelial carcinoma.

## Key findings

- An 81-year-old male with junctional epidermolysis bullosa developed a high-grade papillary urothelial carcinoma of the penile urethra.
- The patient was in remission after partial urethrotomy and had no metastasis at diagnosis.
- Chronic inflammation and fibrosis from the skin condition may have contributed to the tumor's development.

## Abstract

Junctional epidermolysis bullosa is a rare autosomal recessive genetic dermatosis which is characterised by cutaneous and mucosal blistering. Cutaneous squamous cell carcinomas arising in areas of chronic wounds and scarring are a well‐recognised complication. Mucosal involvement of the respiratory, urogenital and gastrointestinal tract can occur, though reports of associated mucosal carcinomas are scarce. We present a case of an 81‐year‐old male with junctional epidermolysis bullosa, multiple metastatic cutaneous squamous cell carcinomas and a papillary urothelial carcinoma. He was diagnosed with an invasive, high‐grade pT2 papillary urothelial carcinoma of the penile urethra at age 74. This was initially identified by the patient as a nonhealing ulcer adjacent to the penile meatus on a background of recurrent blistering of the glans penis. Staging imaging revealed no nodal enlargement or distant metastasis. Management included a partial urethrotomy of the penile urethra, and he is currently in remission. We hypothesise that the urothelial carcinoma may have developed secondary to a permissive tumour microenvironment, which results from chronic inflammation and fibrosis in junctional epidermolysis bullosa.

## Linked entities

- **Diseases:** Junctional epidermolysis bullosa (MONDO:0017612)

## Full-text entities

- **Genes:** NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, LAMB3 (laminin subunit beta 3) [NCBI Gene 3914] {aka AI1A, BM600-125KDA, JEB1A, JEB1B, LAM5, LAMNB1}
- **Diseases:** papillary urothelial carcinoma (MESH:D002291), pemphigus vegetans (MESH:D010392), chronic urinary tract injury (MESH:D014570), mucosal carcinomas (MESH:D052016), keratoacanthoma (MESH:D007636), nodal (MESH:D013611), erosions (MESH:D014077), ulcer (MESH:D014456), hydronephrosis (MESH:D006869), bladder hypertrophy (MESH:D006984), dental disease (MESH:D009057), hypothyroidism (MESH:D007037), urinary retention (MESH:D016055), Urothelial Carcinoma (MESH:D014523), blisters (MESH:D001768), lipodermatosclerosis (MESH:C537026), urogenital carcinoma (MESH:D014565), rheumatoid arthritis (MESH:D001172), metastases (MESH:D009362), lentigo maligna (MESH:D018327), Cutaneous squamous cell carcinomas (MESH:D002294), burns (MESH:D002056), JEB (MESH:D016109), Meatal stenosis (MESH:D003251), cryptococcus (MESH:D003453), enamel dysplasia (OMIM:204690), autosomal recessive genetic dermatosis (MESH:D030342), bladder (MESH:D001745), Cushing's syndrome (MESH:D003480), ischemic cardiomyopathy (MESH:D009202), recessive dystrophic EB (MESH:D016108), oncogenesis (MESH:D063646), transitional cell carcinoma of the bladder (MESH:D002295), lymphadenopathy (MESH:D008206), cutaneous (MESH:D018366), alopecia (MESH:D000505), skin cancers (MESH:D012878), venous insufficiency (MESH:D014689), dystrophic nails (MESH:C536378), carcinoma (MESH:D009369), EB (MESH:D004820), Fitzpatrick skin phototype 2 (MESH:D012871), Chronic wounds (MESH:D014947), Chronic inflammation (MESH:D007249), fibrosis (MESH:D005355)
- **Chemicals:** eosin (MESH:D004801), hydroxychloroquine (MESH:D006886), haematoxylin (MESH:D006416)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.562A > G, 1132+5G > A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927908/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927908/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927908/full.md

---
Source: https://tomesphere.com/paper/PMC12927908